Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 22:35:43 UTC
Update Date2022-11-23 22:29:21 UTC
HMDB IDHMDB0259747
Secondary Accession NumbersNone
Metabolite Identification
Common NameValeryl 4-hydroxy valsartan
Description2-(1-hydroxypropan-2-yl)-3-oxo-2-(N-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)heptanoic acid belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Based on a literature review very few articles have been published on 2-(1-hydroxypropan-2-yl)-3-oxo-2-(N-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)heptanoic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). Valeryl 4-hydroxy valsartan is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Valeryl 4-hydroxy valsartan is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
2-(1-Hydroxypropan-2-yl)-3-oxo-2-(N-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)heptanoateGenerator
Chemical FormulaC29H37N5O5
Average Molecular Weight535.645
Monoisotopic Molecular Weight535.279469311
IUPAC Name2-(1-hydroxypropan-2-yl)-3-oxo-2-(N-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)heptanoic acid
Traditional Name2-(1-hydroxypropan-2-yl)-3-oxo-2-(N-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)heptanoic acid
CAS Registry NumberNot Available
SMILES
CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)C(C(C)CO)(C(O)=O)C(=O)CCCC
InChI Identifier
InChI=1S/C29H37N5O5/c1-4-6-12-25(36)29(28(38)39,20(3)19-35)34(26(37)13-7-5-2)18-21-14-16-22(17-15-21)23-10-8-9-11-24(23)27-30-32-33-31-27/h8-11,14-17,20,35H,4-7,12-13,18-19H2,1-3H3,(H,38,39)(H,30,31,32,33)
InChI KeyJXPAKNRYZWHNII-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentN-acyl-alpha amino acids
Alternative Parents
Substituents
  • Acyl-homoserine
  • N-acyl-alpha-amino acid
  • Biphenyl
  • Phenyltetrazole
  • Medium-chain keto acid
  • Methyl-branched fatty acid
  • Hydroxy fatty acid
  • Heterocyclic fatty acid
  • Branched fatty acid
  • Beta-keto acid
  • Amino fatty acid
  • Fatty acyl
  • Benzenoid
  • N-acyl-amine
  • Keto acid
  • Beta-hydroxy ketone
  • Monocyclic benzene moiety
  • Heteroaromatic compound
  • Tetrazole
  • Tertiary carboxylic acid amide
  • Azole
  • Ketone
  • Carboxamide group
  • Azacycle
  • Organoheterocyclic compound
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Primary alcohol
  • Organooxygen compound
  • Organonitrogen compound
  • Carbonyl group
  • Alcohol
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.38ALOGPS
logP5.49ChemAxon
logS-4.3ALOGPS
pKa (Strongest Acidic)4.06ChemAxon
pKa (Strongest Basic)-0.47ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area149.37 ŲChemAxon
Rotatable Bond Count15ChemAxon
Refractivity160.18 m³·mol⁻¹ChemAxon
Polarizability57.89 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+226.9332859911
AllCCS[M+H-H2O]+225.47932859911
AllCCS[M+Na]+228.61632859911
AllCCS[M+NH4]+228.24432859911
AllCCS[M-H]-216.47932859911
AllCCS[M+Na-2H]-218.6332859911
AllCCS[M+HCOO]-221.13332859911
DeepCCS[M+H]+220.03130932474
DeepCCS[M-H]-217.63530932474
DeepCCS[M-2H]-250.52730932474
DeepCCS[M+Na]+225.94330932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
valeryl 4-hydroxy valsartanCCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)C(C(C)CO)(C(O)=O)C(=O)CCCC4514.6Standard polar33892256
valeryl 4-hydroxy valsartanCCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)C(C(C)CO)(C(O)=O)C(=O)CCCC3296.5Standard non polar33892256
valeryl 4-hydroxy valsartanCCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)C(C(C)CO)(C(O)=O)C(=O)CCCC4092.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
valeryl 4-hydroxy valsartan,3TMS,isomer #1CCCC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)(C(C)CO[Si](C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=N[NH]N=N2)C=C1)C(=O)CCCC4095.3Semi standard non polar33892256
valeryl 4-hydroxy valsartan,3TMS,isomer #1CCCC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)(C(C)CO[Si](C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=N[NH]N=N2)C=C1)C(=O)CCCC3854.5Standard non polar33892256
valeryl 4-hydroxy valsartan,3TMS,isomer #1CCCC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)(C(C)CO[Si](C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=N[NH]N=N2)C=C1)C(=O)CCCC5195.7Standard polar33892256
valeryl 4-hydroxy valsartan,3TMS,isomer #2CCCCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(C(=O)CCCC)(C(=O)O[Si](C)(C)C)C(C)CO[Si](C)(C)C4191.0Semi standard non polar33892256
valeryl 4-hydroxy valsartan,3TMS,isomer #2CCCCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(C(=O)CCCC)(C(=O)O[Si](C)(C)C)C(C)CO[Si](C)(C)C4056.5Standard non polar33892256
valeryl 4-hydroxy valsartan,3TMS,isomer #2CCCCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(C(=O)CCCC)(C(=O)O[Si](C)(C)C)C(C)CO[Si](C)(C)C5092.6Standard polar33892256
valeryl 4-hydroxy valsartan,3TMS,isomer #3CCCC=C(O[Si](C)(C)C)C(C(=O)O)(C(C)CO[Si](C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(=O)CCCC4264.0Semi standard non polar33892256
valeryl 4-hydroxy valsartan,3TMS,isomer #3CCCC=C(O[Si](C)(C)C)C(C(=O)O)(C(C)CO[Si](C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(=O)CCCC4003.1Standard non polar33892256
valeryl 4-hydroxy valsartan,3TMS,isomer #3CCCC=C(O[Si](C)(C)C)C(C(=O)O)(C(C)CO[Si](C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(=O)CCCC5301.3Standard polar33892256
valeryl 4-hydroxy valsartan,3TMS,isomer #4CCCC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)(C(C)CO)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(=O)CCCC4218.3Semi standard non polar33892256
valeryl 4-hydroxy valsartan,3TMS,isomer #4CCCC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)(C(C)CO)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(=O)CCCC3981.7Standard non polar33892256
valeryl 4-hydroxy valsartan,3TMS,isomer #4CCCC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)(C(C)CO)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(=O)CCCC5278.8Standard polar33892256
valeryl 4-hydroxy valsartan,4TMS,isomer #1CCCC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)(C(C)CO[Si](C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(=O)CCCC4260.1Semi standard non polar33892256
valeryl 4-hydroxy valsartan,4TMS,isomer #1CCCC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)(C(C)CO[Si](C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(=O)CCCC3973.6Standard non polar33892256
valeryl 4-hydroxy valsartan,4TMS,isomer #1CCCC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)(C(C)CO[Si](C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C1)C(=O)CCCC4957.8Standard polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #1CCCC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)(C(C)CO[Si](C)(C)C(C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=N[NH]N=N2)C=C1)C(=O)CCCC4564.5Semi standard non polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #1CCCC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)(C(C)CO[Si](C)(C)C(C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=N[NH]N=N2)C=C1)C(=O)CCCC4444.0Standard non polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #1CCCC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)(C(C)CO[Si](C)(C)C(C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=N[NH]N=N2)C=C1)C(=O)CCCC5195.8Standard polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #2CCCCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C(C)(C)C)N=N2)C=C1)C(C(=O)CCCC)(C(=O)O[Si](C)(C)C(C)(C)C)C(C)CO[Si](C)(C)C(C)(C)C4630.7Semi standard non polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #2CCCCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C(C)(C)C)N=N2)C=C1)C(C(=O)CCCC)(C(=O)O[Si](C)(C)C(C)(C)C)C(C)CO[Si](C)(C)C(C)(C)C4641.1Standard non polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #2CCCCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C(C)(C)C)N=N2)C=C1)C(C(=O)CCCC)(C(=O)O[Si](C)(C)C(C)(C)C)C(C)CO[Si](C)(C)C(C)(C)C5097.9Standard polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #3CCCC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O)(C(C)CO[Si](C)(C)C(C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C(C)(C)C)N=N2)C=C1)C(=O)CCCC4694.4Semi standard non polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #3CCCC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O)(C(C)CO[Si](C)(C)C(C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C(C)(C)C)N=N2)C=C1)C(=O)CCCC4559.1Standard non polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #3CCCC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O)(C(C)CO[Si](C)(C)C(C)(C)C)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C(C)(C)C)N=N2)C=C1)C(=O)CCCC5296.1Standard polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #4CCCC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)(C(C)CO)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C(C)(C)C)N=N2)C=C1)C(=O)CCCC4664.3Semi standard non polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #4CCCC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)(C(C)CO)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C(C)(C)C)N=N2)C=C1)C(=O)CCCC4563.9Standard non polar33892256
valeryl 4-hydroxy valsartan,3TBDMS,isomer #4CCCC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)(C(C)CO)N(CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C(C)(C)C)N=N2)C=C1)C(=O)CCCC5277.2Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TMS_1_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TMS_1_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TMS_2_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TMS_2_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TMS_2_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TMS_2_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TMS_2_5) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TMS_2_6) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TBDMS_1_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TBDMS_1_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TBDMS_2_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TBDMS_2_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TBDMS_2_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TBDMS_2_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TBDMS_2_5) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Valeryl 4-hydroxy valsartan GC-MS (TBDMS_2_6) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]